PHOTOSENSITIZING AGENTS PHOTODYNAMIC THERAPY

Brand Owner (click to sort) Address Description
DESTROYING CANCER AT THE SPEED OF LIGHT Theralase Technologies Inc. 41 Hollinger Road Toronto M4B3G4 Canada Photosensitizing agents for photodynamic therapy, namely, light-activated compounds in the nature of therapeutic agents for killing tumor cells and other hyperproliferating cells; photosensitizing agents for photo-activated disinfection, namely, light-activated therapeutic agents for killing pathogens; light-activated disinfectant compositions in the nature of disinfectants for killing pathogens; light-activated photosensitizing compositions in the nature of therapeutic agents for killing tumor cells;
HEALING THE WORLD, ONE PATIENT AT A TIME Theralase Technologies Inc. 41 Hollinger Road Toronto M4B3G4 Canada Photosensitizing agents for photodynamic therapy, namely, light-activated compounds in the nature of therapeutic agents for killing tumor cells and other hyperproliferating cells; photosensitizing agents for photo-activated disinfection, namely, light-activated therapeutic agents for killing pathogens; light-activated disinfectant compositions in the nature of disinfectants for killing pathogens; light-activated photosensitizing compositions in the nature of therapeutic agents for killing tumor cells;HEALING THE WORLD 1 PATIENT AT A TIME;
RUTHERRIN Theralase Technologies Inc. 41 Hollinger Road Toronto M4B3G4 Canada photosensitizing agents for photodynamic therapy, namely, light-activated compounds in the nature of therapeutic agents for killing tumor cells and other hyperproliferating cells; photosensitizing agents for photo-activated disinfection, namely, light-activated therapeutic agents for killing pathogens; light-activated disinfectant compositions in the nature of disinfectants for killing pathogens; light-activated photosensitizing compositions in the nature of therapeutic agents for killing tumor cells;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention involves a methods and compositions for use in photodynamic therapy. Novel perylenequinone derivatives, conjugates comprising perylenequinone derivatives and a binding agent, and methods of treatment using these compositions are disclosed. The present invention relates to the field of photosensitizers possessing photodynamic activities. They possess high photodynamic activities and low dark toxicities, which makes them as more potent photodynamic agents than HPD against cancer and AIDS virus.